Langerhans cell deficiency in reticular dysgenesis

Blood

Volumn 96, Issue 1, 2000, Pages 58-62

  Emile, Jean François ^a   Geissmann, Frédéric ^b   De La Calle Martin, Oscar ^b   Radford Weiss, Isabelle ^b   Lepelletier, Yves ^b   Heymer, Berno ^b   Espanol, Teresa ^b   De Santes, Ken B ^b   Bertrand, Yves ^b   Brousse, Nicole ^b   Casanova, Jean Laurent ^b   Fischer, Alain ^b  

^a HÔPITAL PAUL BROUSSE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LANGERHANS CELL DEFICIENCY; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; RETICULAR DYSGENESIS; RETICULUM CELL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATROPHY; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CHILD; DENDRITIC CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; LYMPHOID TISSUE; MACROPHAGES; SEVERE COMBINED IMMUNODEFICIENCY; SKIN;

EID: 0034234509     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991; 9:271.
2. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245.
3. Romani N, Lenz A, Glassel H, et al. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol. 1989;93:600.
4. Teunissen MBM. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells. Histochem J. 1992;24:697.
5. Emile JF, Fraitag S, Leborgne M, De Prost Y, Brousse N. Langerhans' cell histiocytosis cells are activated Langerhans' cells. J Pathol. 1994; 174:71.
6. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-αa cooperate in the generation of dendritic Langerhans cells. Nature. 1992;360:258.
7. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor β1, in presence of granulocyte/macrophage colony-stimulating factor and IL-4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med. 1998;187: 961.
8. Emile JF, Haddad E, Fraitag S, Canioni D, Fischer A, Brousse N. Detection of donor-derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantation. Br J Haematol. 1997;98:480.
9. Borkowski TA, Letterio JJ, Farr AG, Udey MC. A role of endogenous transforming growth factor b1 in Langerhans cell biology: the skin of transforming growth factor b1 null mice is devoid of epidermal Langerhans cells. J Exp Med. 1996;184: 2417.
10. Borkowski TA, Letterio JJ, Mackall CL, et al. A role for TGF beta 1 in Langerhans cell biology: further characterization of the epidermal Langerhans cell defect in TGF beta 1 null mice. J Clin Invest. 1997;100:575.
11. Emile JF, Durandy A, Le Deist F, Fischer A, Brousse N. Epidermal Langerhans' cells in children with primary T-cell immune deficiencies. J Pathol. 1997;183:70.
12. WHO scientific group. Primary immunodeficiency diseases. Clin Exp Immunol. 1995;99(suppl 1): 2-15.
13. de Vaal OM, Seynhaeve V. Reticular dysgenesia. Lancet. 1959;ii:1123.
14. Gitlin D, Vawter G, Craig JM. Thymic alymphoplasia and congenital aleukocytosis. Pediatrics. 1964;33:184.
15. Alonso K, Dew JM, Starke WR. Thymic alymphoplasia and congenital aleukocytosis (relicular dysgenesia). Arch Pathol. 1972;94:179.
16. Ownby DR, Pizzo S, Blackmon L, Gall SA, Buckley RH. Severe combined immunodeficiency with leukopenia (reticular dysgenesis) in siblings: immunologic and histopathologic findings. J Pediatr. 1976;89:382.
17. Heymer B, Niethammer D, Haas R, Meister H, Haferkampf O. Pathologic findings in severe combined immunodeficiency and reticular dysgenesia. Virchows Arch. 1976;370:151.
18. Haas RJ, Niethammer D, Goldmann SF, Heit W, Bienzle U, Kleihauer E. Congenital immunodeficiency and agranulocytosis (reticular dysgenesia). Acta Paediatr Scand. 1977;66:279.
19. Espanol T, Compte J, Alvarez C, Tallada N, Laverde N, Peguero G. Reticular dysgenesis: report of two brothers. Clin Exp Immunol. 1979;38: 615.
20. Levinsky RJ, Tiedeman K. Successful bone-marrow transplantation for reticular dysgenesis. Lancet 1983;i:671.
21. Roper M, Parmley RT, Crist WM, Kelly DR, Cooper MD. Severe combined leukopenia (reticular dysgenesis): immunologic and morphologic characterizations of leukocytes. Am J Dis Child. 1985; 139:832.
22. Haas A, Wells J, Chin T, Stiehm ER. Successful treatment of reticular dysgenesis with haploidentical bone marrow transplantation [abstract]. Clin Res. 1986;34:127.
23. Chin TW, Plaeger-Marshall S, Haas A, Ank BJ, Stiehm ER. Lymphokine-activated killer cells in primary immunodeficiencies and acquired immunodeficiency syndrome. Clin Immunol Immunopathol. 1989;53:449.
24. Heymer B, Friedrich W, Knobloch C, Goldmann SF. Reticular dysgenesis: primary disorder in differentiation of hematopoietic stem cells? Verh Dtsch Ges Path. 1960;74:106.
25. Bujan W, Ferster A, Azzi N, Devalck C, Leriche A, Sariban E. Use of recombinant human granulocyte colony stimulating factor in reticular dysgenesis. Br J Haematol. 1992;81:128.
26. Stephan JL, Vlekova V, Le Deist F, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr. 1993;123:564.
27. Bujan W, Ferster A, Sariban E. Effect of recombinant human granulocyte colony-stimulating factor in reticular dysgenesis. Blood. 1993;82:1684.
28. Azcona C, Alzina V, Barona P, Sierrasumaga L, Villa-Elizaga I. Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis. Eur J Pediatr. 1994;153:164.
29. De Santes KB, Lai SS, Cowan MJ. Haploidentical bone marrow transplantation for two patients with reticular dysgenesis. Bone Marrow Tranplant. 1996;17:1171.
30. Buckley RC, Schiff RI, Schiff SE, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 1997;130:373.
31. De La Calle-Martin O, Badell I, Garcia A, et al. B cells and monocytes are not developmentally affected in a case of reticular dysgenesis. Clin Exp Immunol. 1997;110:392.
32. Fischer A, Landais P, Friedrich W, et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood. 1994;83:1149.
33. Friedrich W, Goldmann SF, Ebell W, et al. Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors. Eur J Pediatr. 1935;144: 125.
34. Niehues T, Schwarz K, Schneider M, et al. Severe combined immunodeficiency (SCID) associated neutropenia: a lesson from monozygotic twins. Arch Dis Child. 1996;74:340.
35. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol. 1997;27:431.
36. Massey HM, Flanagan AM. Human osteoclasts derive from CD14-positive monocytes. Br J Haematol. 1999;106:167.
37. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med. 1994;179:1109.
38. Witmer-Pack MD, Hughes DA, Schuler G, et al. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci. 1993;104:1021.
39. Shull M, Ormsby I, Kier A, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693.
40. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994;265:1573.
41. Scott EW, Fisher RC, Oison MC, Kehrli EW, Simon MC, Singh H. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity. 1997;6:437.